Overview

Clinical Trial With Mesalamine 1g Suppositories

Status:
Terminated

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

An Investigator-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Establish Therapeutic Equivalence of 1000 mg Mesalamine Rectal Suppositories and Canasa® Rectal Suppositories (1000 mg Mesalamine, USP) in the Treatment of Mild to Moderate Ulcerative Proctitis will be conducted in 533 patient with a estimated duration of 18months.

Phase:

Phase 3

Details

Lead Sponsor:

Sandoz

Treatments:

Mesalamine